10:48 AM EDT, 09/20/2024 (MT Newswires) -- Evotec (EVO) said Friday it opened its J.POD biologics development and manufacturing facility in Toulouse, France.

The facility, launched by the company's Just - Evotec Biologics unit, is expected to be operational in the second of 2024, and will enhance clinical and commercial biologics manufacturing capacity, the company said.

Evotec shares fell more than 6% in recent trading.

Price: 3.41, Change: -0.23, Percent Change: -6.32